Treatment with fitusiran for prophylaxis resulted in a lower rate of bleeding events and improved health-related quality of life in patients with haemophilia A or B with inhibitors.
A JAK2V617F variant with an allele frequency of over 50% is associated with a higher risk of venous thrombosis in patients with polycythaemia vera (PV).
Significant disparities in health outcomes were observed across race, ethnicity, and socioeconomic status (SES) in patients with acute lymphoblastic leukaemia (ALL).
Combination therapy of eprenetapopt plus azacytidine showed efficacy and safety in patients with TP53-mutant myelodysplastic syndrome and oligoblastic acute myeloid leukaemia.
CPX-351 therapy did not result in different overall survival (OS) outcomes or response rates than venetoclax plus HMA therapy in patients with acute myeloid leukaemia (AML) between 60 and 75 years of age.
The dual therapy demonstrated durable and deep responses in heavily pre-treated patients with refractory MM. The combination regimen was tolerable and did not show overlapping toxicity. It is therefore a promising option for treating patients with MM.
The combination regimen of low-dose tacrolimus plus high-dose dexamethasone provides benefits over high-dose dexamethasone monotherapy in patients with immune thrombocytopenia (ITP), promising first-line treatment for patients with ITP.
An annotated guide to the Guidelines for Home Treatment of SARS-CoV-2 infections - by Dr Carla Bruschelli
The Roman legions are considered a model of military efficiency. Military medicine was structured, including Greek influences and rituals, to provide care to these exceptional combatants.
Ethnic or religion-based forms of discrimination against trained medical specialists and the influence of National Socialism in neurology were topics of focus at the DGN 2021.
One click to optimal prevention, diagnosis and therapy: The German Fraunhofer Institutes present the first prototype of a digital patient model as part of the MED²ICIN lead project.
Most rheumatism drugs can be used safely in SARS-CoV-2 infections. Some even seem to protect against severe cases, but individual drugs were associated with a complicated disease path.
The Satelia platform combines algorithms and people. The result is that many hospitalisations are avoided.
Recent advances in immuno-oncology could open up new treatment options for cardiovascular diseases in the future. A team from Heidelberg (Germany) and Stanford (USA) has found decisive steps in this direction.
The American College of Physicians has announced that it is partnering with YouTube to create educational content to combat misinformation about Covid-19 treatment and vaccines.
Dr. Bianco shares his thoughts on the condition of hospitalised patients, in particular the elderly, and stresses the importance of humanising care in the medical profession.
An international team succeeds on the path to better understand the manifestations of this hereditary disease.
Interview with Dr. Giuliano Piccoliori, physician in South Tyrol and scientific head of the Institute of General Medicine and Public Health in Bolzano on the current situation and future of general medicine.
Conference Chair and APAAACI President Prof. Ruby Pawankar talks about the highlights of this year's APAAACI Conference. Prof. Pawankar shares her thoughts about allergy prevention, the challenges of the global pandemic and the impact of her research on the next generation.
Subcutaneous and sublingual immunotherapy (SCIT, SLIT) are the most common methods for controlling allergic rhinitis (AR). At this year's APAAACI Congress, Prof. M. Okano, MD, presented research on the safety, efficacy and adherence of the two treatment regimens.